Anumana Receives U.S. FDA 510(k) Clearance for ECG-AI Algorithm to Detect Low Ejection Fraction
Based on pioneering research from Mayo Clinic, ECG-AI LEF aims to aid physicians in identifying low ejection fraction in patients...
News
Mevion and RaySearch: A Synergy of Innovation Transforming Proton Therapy
Mevion and RaySearch re-imagine novel solutions to advance the use of emerging proton therapy technologies and empower medical providers to...
Vitaquest International Acquires Ashland Powder Processing Facility
Fluidized Bed Process Technologies will Enable Particle and Powder Engineering for Company's Dietary Supplement and Food & Beverage Commercialization BusinessWest...
Cassava Sciences Completes Patient Enrollment for Pivotal Phase 3 Clinical Trial of Oral Simufilam in Alzheimer’s Disease
804 Alzheimer’s Patients Are Enrolled in a Pivotal Phase 3 Clinical TrialA Second Pivotal Phase 3 Clinical Trial Is Expected...
NeuroMetrix and the National Fibromyalgia Association to Collaborate to Improve the Quality of Life for People Living with Fibromyalgia
WOBURN, Mass., Oct. 02, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) announced that it has been selected as a...
Edward Owusu Kwarteng, Ph.D., BSc, MSc, Honored With The 2023 ASH-CIBMTR-ASTCT Career Development Award
NMDP/Be The Match and the CIBMTR, leaders in Cell Therapy research, provide the award to support future leaders and accelerate...
Vivimu Unveils Groundbreaking Compassionate Care Initiative: A 1 Billion MG Hemp-Derived Cannabinoid Giveaway Program
GOLDEN, Colo., Oct. 02, 2023 (GLOBE NEWSWIRE) -- In a bold move to democratize access to quality hemp-derived products, Vivimu.com...
Coherus Applauds Congressional Designation of September 30th as Rare Cancer Day
- Bipartisan resolution highlights the challenges patients with rare cancers face and raises awareness and supports efforts to improve early...
Nanox to Host Investor Day on October 17, 2023
NEVE ILAN, Israel, Oct. 02, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative...
Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering
NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a medical technology company...
Clade Therapeutics Announces the Acquisition of Gadeta B.V.
Expands Clade’s pipeline and broadens its platform with:- proprietary gamma/delta (g/d) TCR universal targeting platform technology,- g/d TCR candidate integrated...
Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration
Refinancing of Current $400M Debt at Lower Cost and Improved Amortization Schedule Blackstone to also Purchase $30M of Amicus Common...
Axonics to Report Third Quarter 2023 Financial Results on October 30
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the...
Mark Cuban Cost Plus Drug Company, PBC Joins Forces with Famlee to Revolutionize Access to Home-Based Step-Therapy Fertility Treatment, Providing an Affordable Path to Parenthood
PORTLAND, OR / ACCESSWIRE / October 2, 2023 / Famlee is revolutionizing the landscape of affordable and accessible women's fertility...
Supporting Indigenous Communities: LifeLabs’ Efforts to Provide Health Equity on National Day of Truth and Reconciliation
Marianne McRae, LifeLabs Mobile Laboratory Assistant Marianne McRae, Mobile Laboratory Assistant visiting Qualicum First Nations clinicToronto, Ontario, Sept. 30, 2023...
SmileDirectClub Seeks to Execute Comprehensive Recapitalization to Strengthen the Business for Sustainable Growth
Company Intends to Maintain Normal Operations, Transforming Smiles Without DisruptionNASHVILLE, Tenn., Sept. 29, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq:...
Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform...
GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression
DUBLIN, Ireland, Sept. 29, 2023 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming...
Vision Sensing Acquisition Corp. Announces Intention to Extend Period to Consummate Initial Business Combination to November 3, 2023
MIAMI, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”), a special purpose...
Interim results for the six months ended 30 June 2023
29 September 2023 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Interim results for the six months ended 30 June 2023 Biodexa...